Prediction of fetal growth restriction using estimated fetal weightvsa combined screening model in the third trimester

2017 ◽  
Vol 50 (5) ◽  
pp. 603-611 ◽  
Author(s):  
J. Miranda ◽  
M. Rodriguez-Lopez ◽  
S. Triunfo ◽  
M. Sairanen ◽  
H. Kouru ◽  
...  
Keyword(s):  
Fetal Growth ◽  
Fetal Growth Restriction ◽  
Growth Restriction ◽  
Third Trimester ◽  
The Third ◽  
Screening Model

scholarly journals Genetic Background of Fetal Growth Restriction

2021 ◽  
Vol 23 (1) ◽  
pp. 36
Author(s):  
Beata Anna Nowakowska ◽  
Katarzyna Pankiewicz ◽  
Urszula Nowacka ◽  
Magdalena Niemiec ◽  
Szymon Kozłowski ◽  
...  
Keyword(s):  
Fetal Growth ◽  
Fetal Growth Restriction ◽  
Metabolic Diseases ◽  
Prenatal Testing ◽  
Growth Restriction ◽  
Chromosomal Microarray ◽  
Third Trimester ◽  
Noninvasive Prenatal Testing ◽  
Current State

Fetal growth restriction (FGR) is one of the most formidable challenges in present-day antenatal care. Pathological fetal growth is a well-known factor of not only in utero demise in the third trimester, but also postnatal morbidity and unfavorable developmental outcomes, including long-term sequalae such as metabolic diseases, diabetic mellitus or hypertension. In this review, the authors present the current state of knowledge about the genetic disturbances responsible for FGR diagnosis, divided into fetal, placental and maternal causes (including preeclampsia), as well as their impact on prenatal diagnostics, with particular attention on chromosomal microarray (CMA) and noninvasive prenatal testing technique (NIPT).

scholarly journals Contingentversusroutine third-trimester screening for late fetal growth restriction

2016 ◽  
Vol 47 (1) ◽  
pp. 81-88 ◽  
Author(s):  
S. Triunfo ◽  
F. Crovetto ◽  
E. Scazzocchio ◽  
M. Parra-Saavedra ◽  
E. Gratacos ◽  
...  
Keyword(s):  
Fetal Growth ◽  
Fetal Growth Restriction ◽  
Growth Restriction ◽  
Third Trimester ◽  
Trimester Screening
Sign in / Sign up

Export Citation Format

Share Document